PACIRA BIOSCIENCES, INC. Commercial Paper, at Carrying Value
PACIRA BIOSCIENCES, INC. (PCRX) had Commercial Paper, at Carrying Value of $19.00 million as of 2021-12-31, per its 10-K filed 2023-02-28.
Discontinued › Notes › Cash Equivalents, at Carrying Value
us-gaap:CommercialPaperAtCarryingValue · last filed 2023-02-28
- 2021-12-31: Commercial Paper, at Carrying Value $19.00M.
- 2020-12-31: Commercial Paper, at Carrying Value $6.50M.
- 2019-12-31: Commercial Paper, at Carrying Value $6.50M.
- 2018-12-31: Commercial Paper, at Carrying Value $21.40M.
| Period end | Commercial Paper, at Carrying Value |
|---|---|
| 2021-12-31 | $19.00M 10-K · filed 2023-02-28 |
| 2020-12-31 | $6.50M 10-K · filed 2022-02-28 |
| 2019-12-31 | $6.50M 10-K · filed 2021-03-01 |
| 2018-12-31 | $21.40M 10-K · filed 2020-02-21 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Janux Therapeutics, Inc. (JANX) | United States | $1.019B | -9.15 |
| MoonLake Immunotherapeutics (MLTX) | Switzerland | $1.031B | -5.43 |
| Savara Inc (SVRA) | United States | $1.044B | -9.10 |
| Corvus Pharmaceuticals, Inc. (CRVS) | United States | $0.994B | -23.25 |
| MANNKIND CORP (MNKD) | United States | $1.058B | -30.41 |
| Alto Neuroscience, Inc. (ANRO) | United States | $1.065B | -11.02 |
| Kura Oncology, Inc. (KURA) | United States | $0.967B | -3.29 |
| Arbutus Biopharma Corp (ABUS) | $0.965B | 6.19 | |
| Jade Biosciences, Inc. (JBIO) | United States | $0.936B | -9.21 |
| Amphastar Pharmaceuticals, Inc. (AMPH) | United States | $1.116B | 10.93 |